Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Synjardy 5/1000?

See the DrugPatentWatch profile for Synjardy

Synjardy 5 / 1000
(5 mg empagliflozin + 1000 mg metformin)


What is Synjardy?

Synjardy is a fixed‑dose combination tablet that contains metformin (an oral biguanide) and empagliflozin (an SGLT‑2 inhibitor). It’s approved for adults with type 2 diabetes mellitus (T2DM) as part of a comprehensive treatment plan that includes diet, exercise, and weight management.

Component Typical dose in Synjardy Role
Empagliflozin 10 mg, 25 mg (sometimes 5 mg) Lowers blood glucose by promoting urinary glucose excretion
Metformin 500 mg, 1000 mg Inhibits hepatic gluconeogenesis, improves insulin sensitivity, and delays glucose absorption

The 5 / 1000 version is less common than the 10 / 500 or 10 / 1000 combinations, but it can be prescribed in certain clinical situations—e.g., when a patient needs a lower empagliflozin exposure (perhaps due to kidney function, drug interactions, or side‑effect profile) but still requires a high metformin dose.


Typical Indications

  • Adults with T2DM whose blood‑glucose control is not adequately managed with metformin alone.
  • Added to metformin monotherapy to achieve tighter glycemic targets.
  • May also be considered for patients with established atherosclerotic cardiovascular disease (ASCVD) or heart failure with reduced ejection fraction (HFrEF) because empagliflozin has proven cardiovascular benefits.

How to Take Synjardy 5 / 1000

Step What to Do Notes
Start 5 mg empagliflozin + 1000 mg metformin once daily, usually with the largest meal
Titrate After 4 weeks, you may discuss with your clinician whether to increase empagliflozin to 10 mg if tolerated Metformin dose is already at 1000 mg; no further increase is typical.
Miss a dose Take it as soon as you remember; if it’s close to the next dose, skip the missed dose (do not double).
Renal function If eGFR drops below 30 mL/min/1.73 m², discontinue empagliflozin (metformin can still be used in certain ranges).

Common Side Effects

Category Symptoms How to manage
Genitourinary Genital mycotic infection, increased urination Keep genital area dry, use topical antifungal if needed
Metabolic Gastrointestinal upset (nausea, vomiting, diarrhea), weight loss Take with food, consider starting at 500 mg metformin if GI upset occurs
Hypoglycemia Low blood glucose (especially when combined with insulin or sulfonylureas) Check glucose regularly; carry fast‑acting carbs
Cardiovascular Dizziness, orthostatic hypotension Monitor BP, avoid abrupt standing
Renal Volume depletion, kidney injury risk Stay hydrated, monitor creatinine

Contraindications & Precautions

Condition Reason Management
Severe renal impairment (eGFR <30 mL/min/1.73 m²) Empagliflozin is renally cleared; risk of accumulation Discontinue empagliflozin
Pregnancy & Lactation Insufficient safety data Avoid use
Type 1 Diabetes Risk of ketoacidosis Not indicated
History of severe genital infections Higher recurrence risk Consider alternative therapy
Cardiovascular status Empagliflozin offers benefit in HFrEF/ASCVD but careful in advanced HF Work with cardiologist

Drug Interactions

Drug Interaction How to Adjust
Insulin & sulfonylureas ↑ risk of hypoglycemia Reduce dose or add glucose monitoring
ACE inhibitors / ARBs Potential additive hypotension Monitor BP
Diuretics ↑ dehydration risk Increase fluid intake, monitor renal function
Corticosteroids ↑ blood glucose Adjust diabetes regimen accordingly
Antacids (aluminum/magnesium) ↓ metformin absorption Take 1–2 h before or after antacids

Monitoring Recommendations

  • HbA1c: every 3 months after initiation, then 6 months if stable.
  • Kidney Function: eGFR and creatinine at baseline, 3 months, then 6 months (or sooner if symptoms).
  • Liver Function: baseline, then periodically if clinically indicated.
  • Weight & BP: at each visit (empagliflozin often causes modest weight loss and BP reduction).
  • Signs of ketoacidosis: unexplained fatigue, nausea, vomiting, or abdominal pain.

Frequently Asked Questions

Question Answer
Can I take this with alcohol? Alcohol may increase the risk of hypotension and GI upset. Limit alcohol or avoid if you experience dizziness or nausea.
What if I miss a dose? Take it when you remember; if it’s near your next dose, skip the missed one. Do not double‑dose.
Will this drug help with my blood pressure? Empagliflozin has mild BP‑lowering effects; combined with other antihypertensives, you may see improvement.
Is this drug safe if I have kidney disease? Only use the empagliflozin portion if eGFR ≥30 mL/min/1.73 m². Metformin is usually avoided or reduced below 30 mL/min/1.73 m².

Bottom Line

  • Synjardy 5 / 1000 combines a low dose of empagliflozin (5 mg) with a high dose of metformin (1000 mg).
  • It’s a viable option when clinicians want to minimize empagliflozin exposure while still maintaining a robust metformin therapy.
  • Follow your prescriber’s guidance on dosing, monitoring, and lifestyle adjustments.

Always consult your healthcare provider before making any changes to your diabetes regimen.



Other Questions About Synjardy :

When does synjardy's licence expire? Synjardy xr manufacturer coupon 2023? Synjardy medication? Synjardy coupon? Synjardy pret? Coupons for synjardy? Synjardy 12.5 mg/1000 mg price?